Company / Current Liabilities per Share
Sarepta Therapeutics Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$11.30
FY2025
5-year range
$5.70 / $11.30
FY2021-FY2025
Trend
+44.8%
vs FY2024
Sector context
#20 of 210
Health Care
What the data says
Among 210 Health Care companies, Sarepta Therapeutics is in the bottom 10% for current liabilities per share. Current Liabilities per Share has increased for 8 consecutive years, from $1.61 in FY2017 to $11.30 in FY2025.
Based on SEC 10-K filings.
11.30 in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Increased from $7.43 to $11.30 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +16.7%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
-52.5% below sector average
Key checks
Key Insights
- Sarepta Therapeutics's current liabilities per share has grown for 8 consecutive years.
- In FY2025, current liabilities per share increased 44.8% year-over-year.
- Ranks #20 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.30 | +44.8% |
| FY2024 | $7.81 | +5.0% |
| FY2023 | $7.43 | +4.5% |
| FY2022 | $7.11 | +24.7% |
| FY2021 | $5.70 | +3.1% |
| FY2020 | $5.53 | +48.5% |
| FY2019 | $3.73 | +39.0% |
| FY2018 | $2.68 | +66.2% |
| FY2017 | $1.61 | -2.4% |
| FY2016 | $1.65 | +12.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026